Native joint infections caused by Parvimonas micra.

Area of Science:

• Microbiology
• Infectious Diseases
• Rheumatology

Background:

• Parvimonas micra is an anaerobic, fastidious, gram-positive bacterium prevalent in the oral and gastrointestinal tracts.
• It is increasingly implicated as a causative agent of septic arthritis in native joints, often presenting with diagnostic delays and significant morbidity.
• Risk factors for P. micra septic arthritis include immunosuppression, joint inflammation, and recent dental procedures or infections.

Purpose of the Study:

• To highlight the growing role of Parvimonas micra in septic arthritis.
• To discuss the challenges in culturing and diagnosing P. micra infections.
• To emphasize the importance of accurate identification and susceptibility testing for effective treatment.

Main Methods:

• Review of clinical cases and literature concerning Parvimonas micra infections.
• Advancements in microbial identification techniques, particularly matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
• Analysis of antibiotic susceptibility patterns and treatment outcomes.

Main Results:

• MALDI-TOF-MS has significantly improved the identification rates of P. micra, previously a difficult organism to culture.
• Delayed diagnosis of P. micra septic arthritis contributes to increased patient morbidity.
• Established antibiotic susceptibilities exist, but testing is essential for guiding treatment in individual cases.

Conclusions:

• Parvimonas micra is an emerging pathogen in septic arthritis, necessitating increased clinical awareness.
• Modern diagnostic tools like MALDI-TOF-MS are crucial for timely and accurate identification.
• Prompt diagnosis coupled with appropriate antibiotic susceptibility testing and treatment (e.g., clindamycin, penicillin, metronidazole) is vital for managing P. micra septic arthritis effectively.